Oncolytics Biotech Inc. Files 6-K Report
Ticker: ONCY · Form: 6-K · Filed: Jun 11, 2025 · CIK: 1129928
Sentiment: neutral
Topics: reporting, foreign-private-issuer, sec-filing
Related Tickers: ONCY
TL;DR
ONCOLYTICS BIOTECH INC (ONCY) filed a 6-K, confirming foreign private issuer status and 20-F annual report filing.
AI Summary
Oncolytics Biotech Inc. filed a Form 6-K on June 11, 2025, reporting as a foreign private issuer. The company is based in Calgary, Alberta, Canada, and operates in the Pharmaceutical Preparations industry. This filing indicates they will file annual reports under Form 20-F.
Why It Matters
This filing provides an update on Oncolytics Biotech Inc.'s reporting status as a foreign private issuer, which is standard for companies with international operations.
Risk Assessment
Risk Level: low — This is a routine administrative filing for a foreign private issuer and does not contain new financial or operational information that would typically increase risk.
Key Players & Entities
- ONCOLYTICS BIOTECH INC (company) — Filer of the 6-K report
- June 11, 2025 (date) — Filing date of the 6-K
- Calgary, Alberta, Canada (location) — Company's principal executive offices
- Form 6-K (document) — Type of SEC filing
- Form 20-F (document) — Annual report form for foreign private issuers
FAQ
What is the primary purpose of this Form 6-K filing?
The primary purpose of this Form 6-K filing is to report Oncolytics Biotech Inc.'s status as a foreign private issuer and to indicate that it files annual reports under Form 20-F.
When was this Form 6-K filed with the SEC?
This Form 6-K was filed with the SEC on June 11, 2025.
Where are Oncolytics Biotech Inc.'s principal executive offices located?
Oncolytics Biotech Inc.'s principal executive offices are located at Suite 804, 322 11th Avenue SW, Calgary, Alberta, Canada T2R 0C5.
Does Oncolytics Biotech Inc. file its annual reports as Form 20-F or Form 40-F?
Oncolytics Biotech Inc. indicates it files its annual reports under cover of Form 20-F.
What is the SIC code for Oncolytics Biotech Inc.?
The Standard Industrial Classification (SIC) code for Oncolytics Biotech Inc. is 2834, which corresponds to Pharmaceutical Preparations.
Filing Details
This Form 6-K (Form 6-K) was filed with the SEC on June 11, 2025 regarding ONCOLYTICS BIOTECH INC (ONCY).